CYP2D6 is apparently involved in the metabolism of drugs.
I imagine they are interested in it as a predictor or whether or not people will respond or not to the biologics, that is whether the body will metabolise and break down the drugs quickly or slowly - thus defining drug efficacy in a given patient?


Dx Oct 2006 B27+ undifferentiated spondlyarthropathy (uSpA) with mild sebhorrhoeic dermatitis and mild Inflammatory Bowel Disease (IBD) controlled by NSD since 2007.